BioCentury
ARTICLE | Clinical News

Aggrastat tirofiban regulatory update

July 18, 2016 7:00 AM UTC

FDA issued a complete response letter to Medicure for an sNDA for Aggrastat tirofiban to treat patients with ST-segment elevation myocardial infarction (STEMI). Medicure said the agency asked for addi...